- Canessa, N., Castronovo, V., Cappa, S. F., Aloia, M. S., Marelli, S., Falini, A., et al. (2011). Obstructive sleep apnea: brain structural changes and neurocognitive function before and after treatment. Am. J. Respir. Crit. 183, 1419–1426. doi: 10.1164/rccm.201005-0693OC
- Chong, M. S., Ayalon, L., Marler, M., Loredo, J. S., Corey-Bloom, J., Palmer, B. W., et al. (2006). Continuous positive airway pressure reduces subjective daytime sleepiness in patients with mild to moderate Alzheimer’s disease with sleep disordered breathing. J. Am. Geriatr. Soc. 54, 2076–2081. doi: 10.1111/j.1532-5415.2006.
00694.x
- Cooke, J. R., Ayalon, L., Palmer, B. W., Loredo, J. S., Corey-Bloom, J., Natarajan, L., et al. (2009). Sustained use of CPAP slows deterioration of cognition, sleep, and mood in patients with Alzheimer’s disease and obstructive sleep apnea: a preliminary study J. Clin. Sleep Med. 15, 305–309. doi: 10.5664/jcsm.27538
- Elias, A., Cummins, T., Tyrrell, R., Lamb, F., Dore, V., Williams, R., et al. (2018). Risk of Alzheimer’s disease in obstructive sleep apnea syndrome: amyloid-β and tau imaging. J. Alzheimers Dis. 66, 733–741. doi: 10.3233/JAD-180640
- Finkel, K. J., Searleman, A. C., Tymkew, H., Tanaka, C. Y., Saager, L., Safer-Zadeh, E., et al. (2009). Prevalence of undiagnosed obstructive sleep apnea among adult surgical patients in an academic medical center. Sleep Med. 10, 753–758. doi: 10.1016/j.sleep.2008.08.007
- Gagnon, K., Baril, A. A., Gagnon, J. F., Fotin, M., Décary, A., Lafond, C., et al. (2014). Cognitive impairment in obstructive sleep apnea. Pathol. Biol. 62, 233–240. doi: 10.1016/j.patbio.2014.05.015
- Ju, Y. S., Zangrilli, M. A., Finn, M. B., Fagan, A. M., and Holtzman, D. M. (2019). Obstructive sleep apnea treatment, slow wave activity, and amyloid-β. Ann. Neurol. 85, 291–295. doi: 10.1002/ana.25408
- Kalaria, R. N., Maestre, G. E., Arizaga, R., Friedland, R. P., Galasko, D., Hall, K., et al. (2008). Alzheimer’s disease and vascular dementia in developing countries: prevalence, management, and risk factors. Lancet Neurol. 7, 812–826. doi: 10.1016/S1474-4422(08)70169-8
- Kong, W., Zheng, Y., Xu, W., Gu, H., and Wu, J. (2020). Biomarkers of Alzheimer’s disease in severe obstructive sleep apnea–hypopnea syndrome in the Chinese population. Eur. Arch. Oto-Rhino-Laryngol. doi: 10.1007/s00405-020-05948-2
- Kuo, C. Y., Stachiv, I., and Nikolai, T. (2020). Association of late life depression, (non-) modifiable risk and protective factors with dementia and Alzheimer’s disease: literature review on current evidences, preventive interventions and possible future trends in prevention and treatment of dementia. Int. J. Environ. Res. Public Health 17:7475. doi: 10.3390/ijerph17207475
- Liguori, C., Mercuri, N. B., Nuccetelli, M., Izzi, F., Cordella, A., Bernardini, S., et al. (2019). Obstructive sleep apnea may induce orexinergic system and cerebral β-amyloid metabolism dysregulation: is it a further proof for Alzheimer’s disease risk? Sleep Med. 56, 171–176. doi: 10.1016/j.sleep.2019.01.003
- Liguori, C., Romigi, A., Nuccetelli, M., Zannino, S., Sancesario, G., Martorana, A., et al. (2017). Obstructive sleep apnea is associated with early but possibly modifiable Alzheimer’s disease biomarkers changes. Sleep 40:zsx011. doi: 10.1093/sleep/zsx011
